Repeated Amiodarone Dosing In Cardiac surgicaL Procedures
Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
This study is a single-center, prospective, randomized, open-label trial of subjects who
develop atrial fibrillation after non-emergent cardiac surgery at the University of Kentucky
Chandler Medical Center (UKCMC). Patients will be randomized to receive either a conventional
amiodarone dosing regimen (CDR) or a repeated amiodarone bolus dosing regimen (RBDR).